ACAD
ACADIA Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.02
+0.57%Margins
Gross margin
91.1%
EBITDA margin
10.2%
EBIT margin
7.6%
Net margin
33.4%
FCF margin
15.3%
29.1%
Return on equity
21.8%
Return on assets
6.3%
Return on invested capital
0.68x
Asset turnover
$194.3M
Cash from operations
$5.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026